4//SEC Filing
Rovaldi Christopher 4
Accession 0001209191-22-006830
CIK 0001664710other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:45 PM ET
Size
5.6 KB
Accession
0001209191-22-006830
Insider Transaction Report
Form 4
Rovaldi Christopher
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-01+100,000→ 100,000 totalExercise: $49.34Exp: 2032-01-31→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the shares subject to the option shall vest on February 1, 2023, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Keros Therapeutics, Inc.
CIK 0001664710
Entity typeother
Related Parties
1- filerCIK 0001706040
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:45 PM ET
- Size
- 5.6 KB